Belle Mead, NJ, United States of America

Yue-Mei Zhang

This inventor holds 49 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Peptide Therapeutics. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Unlimited Company. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue-Mei Zhang. Retrieved from https://idiyas.com/inventor/yue-mei-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 (Patent Applications = 9)

% Patents Active = 71.4

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 8.4

ph-index = 7

Forward Citations = 370(Granted Patents)

Location History:

Belle Mead, NJ (US) (2010 - 2017)
Spring House, PA (US) (2013 - 2017)
Wellesley, MA (US) (2016 - 2023)

Company Filing History:

48 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 64

Janssen Sciences Ireland Unlimited Company

patents

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Immunoglobulins

Cyclic Peptides

GPR Receptors

Neuropeptide Y

GLP-1

Azetidinyl Diamides

Monoacylglycerol Lipase

CB-1 Agonists

Opioid Receptors

Benzothiophenyl Derivatives

Pyrimidine Compounds

Quinoline Derivatives

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134636 - Immunoglobulins and uses thereof (2024-11-05),

2. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2023-10-10),

3. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-09-26),

4. 11732019 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-08-22),

5. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-02-28),

6. 11401315 - Immunoglobulins and uses thereof (2022-08-02),

7. 11230526 - Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors (2022-01-25),

8. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

9. 10968264 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

10. 10961293 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-03-30),

11. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2020-12-29),

12. 10858413 - Immunoglobulins and uses thereof (2020-12-08),

13. 10787495 - Immunoglobulins and uses thereof (2020-09-29),

14. 10662170 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes (2020-05-26),

15. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2020-05-05),

Title: Yue-Mei Zhang: Pioneering Inventor from Belle Mead, NJ

Introduction: Yue-Mei Zhang is a highly accomplished inventor based in Belle Mead, NJ, known for her groundbreaking innovations in various fields.

Latest Patents: Yue-Mei Zhang holds several patents in the areas of biotechnology, renewable energy, and sustainable materials, showcasing her diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Yue-Mei Zhang has been instrumental in developing cutting-edge technologies that have significantly impacted the way we live and work today.

Collaborations: Throughout her career, Yue-Mei Zhang has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of innovation and excellence.

Conclusion: Yue-Mei Zhang's passion for innovation and dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.